NCT02920359View on ClinicalTrials.gov

Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 17, 2016

Primary Completion Date

December 13, 2016

Study Completion Date

September 30, 2017

Conditions
There Are no Conditions Under Study. Healthy Volunteers
Interventions
DRUG

LEUPRORELIN ACETATE

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT02920359 - Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control | Biotech Hunter | Biotech Hunter